Literature DB >> 2526794

Complications of corticosteroid and immunosuppressive drugs.

B Rubin1, A G Palestine.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2526794     DOI: 10.1097/00004397-198902930-00006

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  5 in total

1.  Cyclophosphamide for ocular inflammatory diseases.

Authors:  Siddharth S Pujari; John H Kempen; Craig W Newcomb; Sapna Gangaputra; Ebenezer Daniel; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; C Stephen Foster
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

2.  Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study.

Authors:  M Diestelhorst; F Aspacher; W Konen; G K Krieglstein; R D Hilgers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Biological response modifier therapy for refractory childhood uveitis.

Authors:  Michael Gallagher; Karina Quinones; Rene Antonio Cervantes-Castañeda; Taygan Yilmaz; C Stephen Foster
Journal:  Br J Ophthalmol       Date:  2007-06-07       Impact factor: 4.638

4.  Treatment of uveitis with recombinant human interleukin-13.

Authors:  F G Roberge; M D de Smet; J Benichou; M F Kriete; J Raber; J Hakimi
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

5.  Zoledronate treatment duration is linked to bisphosphonate-related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis.

Authors:  Jonathan G Messer; Jessica M Jiron; Jorge L Mendieta Calle; Evelyn J Castillo; Ronnie Israel; Ean G Phillips; Joshua F Yarrow; Catherine Van Poznak; Lakshmyya Kesavalu; Donald B Kimmel; J Ignacio Aguirre
Journal:  Oral Dis       Date:  2019-02-19       Impact factor: 3.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.